Search Results - "Tambaki, A P"

Laparoscopic surgery-induced changes in oxidative stress markers in human plasma by GLANTZOUNIS, G. K, TSELEPIS, A. D, TAMBAKI, A. P, TRIKALINOS, T. A, MANATAKI, A. D, GALARIS, D. A, TSIMOYIANNIS, E. C, KAPPAS, A. M

“…The induction of the pneumoperitoneum increases intraabdominal pressure (IAP), causing splanchnic ischemia, whereas its deflation normalizes IAP and splanchnic…”
Get full text

Lack of effect of acute repaglinide administration on postprandial lipaemia in patients with type 2 diabetes mellitus by Tentolouris, N, Kolia, M, Tselepis, A D, Perea, D, Kitsou, E, Kyriaki, D, Tambaki, A P, Karabina, S P, Sala, C, Fragoulopoulos, E, Katsilambros, N

“…The effect of acute repaglinide administration (2 mg) on postprandial glycaemia and lipaemia has been examined in 20 subjects with type 2 diabetes mellitus…”
Get more information

Platelet Hyperaggregability to Platelet Activating Factor (PAF) in Non-ST Elevation Acute Coronary Syndromes by Michalis, L. K., Tambaki, A. P., Katsouras, C. S., Goudevenos, J. A., Kolettis, T., Adamides, K., Tselepis, A. D., Sideris, D. A.

“…Summary It is known that myocardial ischaemia increases platelet aggregatory response to various agonists, ex vivo. We investigated the platelet aggregatory…”
Get full text

Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina : effect of c7E3 Fab (abciximab) therapy by TSELEPIS, A. D, GOUDEVENOS, J. A, TAMBAKI, A. P, MICHALIS, L, STROUMBIS, C. S, TSOUKATOS, D. C, ELISAF, M, SIDERIS, D. A

“…Platelet activation and aggregation is a dominant feature in the pathophysiology of unstable angina. The final step of platelet aggregation is mediated through…”
Get full text

Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease by Katsouras, C S, Karabina, S A, Tambaki, A P, Goudevenos, J A, Michalis, L K, Tsironis, L D, Stroumbis, C S, Elisaf, M S, Sideris, D A, Tselepis, A D

“…The aim of this study was to investigate the possible associations between lipoprotein(a) [Lp(a)] concentrations or apolipoprotein(a) isoforms and the mode of…”
Get full text

Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins by Tsimihodimos, Vasilis, Kakafika, Anna, Tambaki, Afroditi P, Bairaktari, Eleni, Chapman, M John, Elisaf, Moses, Tselepis, Alexandros D

“…Human plasma platelet-activating factor acetylhydrolase (PAF-AH) is an enzyme associated mainly with the apolipoprotein B (apoB)-containing lipoproteins and…”
Get full text

Atorvastatin Preferentially Reduces LDL-Associated Platelet-Activating Factor Acetylhydrolase Activity in Dyslipidemias of Type IIA and Type IIB by Tsimihodimos, Vasilis, Karabina, Sonia-Athena P, Tambaki, Afroditi P, Bairaktari, Eleni, Goudevenos, John A, Chapman, M John, Elisaf, Moses, Tselepis, Alexandros D

“…Human plasma platelet-activating factor acetylhydrolase (PAF-AH) is a phospholipase A2 that is primarily associated with low density lipoprotein (LDL). PAF-AH…”
Get full text

Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia by Tsimihodimos, Vasilis, Karabina, Sonia-Athena P, Tambaki, Afroditi P, Bairaktari, Eleni, Miltiadous, George, Goudevenos, John A, Cariolou, Marios A, Chapman, M John, Tselepis, Alexandros D, Elisaf, Moses

“…Platelet-activating factor-acetylhydrolase (PAF-AH) is a lipoprotein-associated phospholipase A2 capable of hydrolyzing platelet-activating factor (PAF) and…”
Get full text

Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome by Rizos, Evangelos, Tambaki, Afroditi P., Gazi, Irene, Tselepis, Alexandros D., Elisaf, Moses

“…Plasma- and lipoprotein-associated activity of the platelet activating factor acetylhydrolase (PAF-acetylhydrolase, PAF-AH) plays an important role in…”
Get full text

Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect by Milionis, Haralampos J, Tambaki, Afroditi P, Kanioglou, Chrisa N, Elisaf, Moses S, Tselepis, Alexandros D, Tsatsoulis, Agathocles

“…Subclinical hypothyroidism (SH) has been associated with an increased risk of ischemic heart disease, which has been partly attributed to lipid abnormalities…”
Get more information

Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity by Tambaki, Afroditi P, Rizos, Evangelos, Tsimihodimos, Vasilis, Tselepis, Alexandros D, Elisaf, Moses

“…Human plasma platelet activating factor acetylhydrolase (PAF-AH) is a phospholipase A2 primarily associated with low-density lipoprotein (LDL). PAF-AH activity…”
Get more information

The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity by Kakafika, Anna I, Xenofontos, Stavroula, Tsimihodimos, Vasilis, Tambaki, Afroditi P, Lourida, Evangelia S, Kalaitzidis, Rigas, Cariolou, Marios A, Elisaf, Moses, Tselepis, Alexandros D

“…The platelet-activating factor acetylhydrolase activity associated with high density lipoprotein (HDL-PAF-AH) may substantially contribute to the antioxidant,…”
Get full text